Koyal Jain,Dana V Rizk
Koyal Jain
IgA nephropathy is the most prevalent glomerular disease worldwide. To date, a percutaneous kidney biopsy is needed for diagnosis and assessment of disease activity and prognosis. Histology and generic markers of kidney dysfunction, such as...
Sydney C W Tang,Heather N Reich
Sydney C W Tang
Increased understanding of the pathogenesis of IgA nephropathy (IgAN) has led to the development of new investigational agents tailored to this disease. The identification of surrogate markers of early treatment benefit has facilitated regu...
Approved therapies in the IgA nephropathy armamentarium: a summary of the evidence [0.03%]
IgA肾病治疗药物的循证总结
Sayna Norouzi,Richard A Lafayette
Sayna Norouzi
Historically, IgA nephropathy (IgAN) was managed using supportive care, with a suggested 6 months of immunosuppressive therapy considered for patients at high risk of progressive kidney function decline (proteinuria, >0.75-1 g/d) despite ≥...
IgA nephropathy: an overview of the disease, its pathophysiology, and involvement of the gut-kidney axis [0.03%]
IgA肾病：疾病概览、病理生理及其肠道-肾脏轴参与作用
Chee Kay Cheung,Laura H Mariani
Chee Kay Cheung
IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide. Its incidence and prevalence vary widely, with estimates of annual incidence ranging from 0.06 to 10.5 per 100,000 per year in adults and children. IgAN represe...
Management of IgA nephropathy and the expanding role of immunomodulation [0.03%]
IgA肾病的治疗及免疫调节作用的扩大角色
Pietro A Canetta,Heather N Reich
Pietro A Canetta
IgA nephropathy (IgAN) requires effective long-term management to avoid kidney failure. Proteinuria and reductions in estimated glomerular filtration rate are important clinical markers of progression, and they are established surrogate eff...
China Kidney Disease Network (CK-NET) 2017-2018 Annual Data Report [0.03%]
中国肾脏病网络（CK-NET）2017-2018年度数据报告
Luxia Zhang,Ming-Hui Zhao,Li Zuo et al.
Luxia Zhang et al.
Variations in kidney care management and access: regional assessments of the 2023 International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) [0.03%]
肾脏护理管理和获取情况的地区差异：2023年国际肾病学会全球肾脏健康图集（ISN-GKHA）的区域评估
Aminu K Bello,Ikechi G Okpechi,Adeera Levin et al.
Aminu K Bello et al.
Capacity for the management of kidney failure in the International Society of Nephrology North America and the Caribbean region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA) [0.03%]
国际肾脏病学会全球肾脏健康图谱（ISN-GKHA）报告：北美和加勒比地区肾衰竭管理能力状况报告
Racquel Lowe-Jones,Isabelle Ethier,Lori-Ann Fisher et al.
Racquel Lowe-Jones et al.
The International Society of Nephrology Global Kidney Health Atlas charts the availability and capacity of kidney care globally. In the North America and the Caribbean region, the Atlas can identify opportunities for kidney care improvement...
Capacity for the management of kidney failure in the International Society of Nephrology Western Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA) [0.03%]
国际肾脏病学会全球肾脏健康 atlas(2023 isn-gkha)报告：国际肾脏病学会西方欧洲地区的肾脏衰竭管理能力
Maria Pippias,Gaetano Alfano,Dearbhla M Kelly et al.
Maria Pippias et al.
Western Europe boasts advanced health care systems, robust kidney care guidelines, and a well-established health care workforce. Despite this, significant disparities in kidney replacement therapy incidence, prevalence, and transplant acces...
Capacity for the management of kidney failure in the International Society of Nephrology North and East Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA) [0.03%]
国际肾脏病学会全球肾脏健康图谱（ISN-GKHA）报告：国际肾脏病学会北亚和东亚地区管理肾功能衰竭的能力
Winston Wing-Shing Fung,Hyeong Cheon Park,Yosuke Hirakawa et al.
Winston Wing-Shing Fung et al.
Globally, there remain significant disparities in the capacity and quality of kidney care, as evidenced by the third edition of the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA). In the ISN North and East Asia re...